Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/2010
09/02/2010WO2010098344A1 Tricyclic pyrazolopyrimidine derivative
09/02/2010WO2010098298A1 Pharmaceutical composition comprising combination of compound having nutrient digestion/absorption inhibitory activity and cyclohexanecarboxamide derivative
09/02/2010WO2010098265A1 Polymeric micelle containing proteasome inhibitor
09/02/2010WO2010098080A1 1,4-benzothiazepine-1-oxide derivative and pharmaceutical composition utilizing the same
09/02/2010WO2010097469A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097468A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097467A1 N-phenylacetamide derivatives, which inhibit the enzyme soat-1 and pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010096906A1 Ethyl gallate and related compounds as a treatment for sepsis and septic shock
09/02/2010WO2010096869A1 An agent for improving inotropy and lusitropy, and for treating diseases causing or caused by poor contractility or relaxation of the heart
09/02/2010WO2010062122A9 Composition for preventing or treating artherosclerosis
09/02/2010WO2010057028A9 Treatment of proteinopathies using a farnesyl transferase inhibitor
09/02/2010WO2010048149A3 Heterocyclic modulators of gpr119 for treatment of disease
09/02/2010WO2010019417A3 Chymase inhibitors
09/02/2010US20100222867 Drug delivery from stents
09/02/2010US20100222576 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/02/2010US20100222432 Synthetic Carbon Nanotubes
09/02/2010US20100222431 Novel phenylurea inhibitors of the soat-1 enzyme and pharmaceutical/cosmetic compositions comprised thereof
09/02/2010US20100222424 Method of Screening Drug with the Use of 67 kDa Laminin Receptor and Drug Obtained Thereby
09/02/2010US20100222409 Compositions and methods for inhibiting expression of pro-apoptotic genes
09/02/2010US20100222400 F1F0-ATPase Inhibitors and Related Methods
09/02/2010US20100222399 Thiazolidinedione Analogues For The Treatment Of Hypertension
09/02/2010US20100222398 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
09/02/2010US20100222386 Substituted piperidines
09/02/2010US20100222373 Crystalline Form of Bis [(E)-7-[4-(4-fluoro-phenyl)-6-isopropyl-2-[methyl(methyl-sulfonyl)amino] pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid] Calcium Salt
09/02/2010US20100222366 Piperidine derivatives as modulators of chemokine receptor activity
09/02/2010US20100222365 Substituted triazole deriviatives as oxytocin antagonists
09/02/2010US20100222363 Bicyclic Derivatives as P38 Inhibitors
09/02/2010US20100222362 N-oxides of n-phenyl-2-pyramidine-amine derivatives
09/02/2010US20100222348 Quinolinone derivatives as parp inhibitors
09/02/2010US20100222340 SUBSTITUTED PYRIDO [1,2-a] ISOQUINOLINE DERIVATIVES
09/02/2010US20100222335 Process For The Preparation Of N,N'-Disubstituted Oxabispidines
09/02/2010US20100222334 Pharmaceutical Formulation of Valsartan
09/02/2010US20100222326 New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
09/02/2010US20100222316 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
09/02/2010US20100222315 Patient populations and treatment methods
09/02/2010US20100222307 Vitamin d and vitamin d analogs or derivatives as new anti-hypertensive agents
09/02/2010US20100222300 A2B Adenosine Receptor Antagonists
09/02/2010US20100222298 Spill resistant formulations containing clays
09/02/2010US20100222294 Formulations of ATP and Analogs of ATP
09/02/2010US20100222286 Receptor modulators exhibiting neuroprotective and memory enhancing activities
09/02/2010US20100222285 Method of controlling the proliferation of vascular endothelial cells and inhibiting lumen formation
09/02/2010US20100222284 Composition for inhibiting the onset of arteriosclerosis and inhibition method
09/02/2010US20100222278 Use of leptin for the prevention of excess body weight and composition containing leptin
09/02/2010US20100222276 protease-sensitive site in apolipoprotein a1, therapeutic and diagnostic implications
09/02/2010US20100222274 Glycosylation-deficient hepatocyte growth factor
09/02/2010US20100222270 Heterocyclic compounds as crth2 receptor antagonists
09/02/2010US20100222265 Heparin binding epidermal growth factor (hb-egf) for use in methods of treating and preventing intestinal injury related to hemorrhagic shock and resuscitation
09/02/2010US20100222262 Substituted 1, 3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions
09/02/2010US20100222260 Uses of pegylated albumin
09/02/2010US20100222258 TNF antagonist and TNF inhibitor containing it as an effective ingredient
09/02/2010US20100222257 Substituted phenethylamines
09/02/2010US20100221766 NUCLEAR TRANSFER PROMOTER FOR Cdc42 PROTEIN AND METHOD OF SCREENING THE SAME
09/02/2010US20100221746 Compositions and methods for the treatment of disease
09/02/2010US20100221358 Synthetic derivatives beta glycolipids and compositions thereof for the treatment of pathologic disorders
09/02/2010US20100221348 Therapeutic uses of dunaliella powder
09/02/2010US20100221347 Enhancing solute transport within a tissue scaffold
09/02/2010US20100221340 Method and compositions for treatment or prevention of inflammatory conditions
09/02/2010US20100221330 Buoyant formulations of betaine
09/02/2010US20100221327 Nanoparticulate azelnidipine formulations
09/02/2010US20100221317 Dynamin mediated diseases and associated methods and products
09/02/2010US20100221304 Bionanocomposite Materials and Methods For Producing and Using the Same
09/02/2010US20100221298 Novel galenical system for active transport, method for preparation and use
09/02/2010US20100221268 T cell immunomodulation by placenta cell preparations
09/02/2010US20100221262 Anti-unc5b antibodies and methods of use
09/02/2010US20100221260 Immunoglobulins
09/02/2010US20100221259 Nitrogen-containing heterocyclic compounds and medicinal use thereof
09/02/2010US20100221258 Method of treating a pathological syndrome and a pharmaceutical agent
09/02/2010US20100221257 Binding members-513
09/02/2010US20100221255 Apelin peptides and methods of use
09/02/2010US20100221254 Methods and Compositions for PDGF-C Activation and Inhibition
09/02/2010US20100221243 Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state
09/02/2010US20100221236 Mutants of Staphylokinase Carrying Amino and Carboxy-Terminal Extensions for Polyethylene Glycol Conjugation
09/02/2010US20100221233 Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
09/02/2010US20100221225 Compositions and methods for treating glycogen storage diseases
09/02/2010US20100221221 N-phenyl-2-pyrimidineamine derivatives
09/02/2010US20100221179 IL-1 Binding Proteins
09/02/2010CA2790906A1 Composition and methods for clotting blood
09/02/2010CA2753434A1 Soluble guanylate cyclase activators
09/02/2010CA2753426A1 Coenzyme q10-containing composition for oral ingestion
09/02/2010CA2753345A1 1,4-benzothiazepine-1-oxide derivative and pharmaceutical composition utilizing the same
09/02/2010CA2753304A1 Tricyclic pyrazolopyrimidine derivatives as hsp inhibitors
09/02/2010CA2751299A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010CA2751296A1 Novel n-phenylacetamide derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010CA2751279A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, pharmaceutical and cosmetic compositions containing them
09/01/2010EP2223932A1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
09/01/2010EP2223922A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
09/01/2010EP2223920A2 Substituted azabicyclic compounds
09/01/2010EP2222666A1 Crystalline polymorph of doxazosin mesylate (form iv) and process for preparation thereof
09/01/2010EP2222649A2 Novel crystalline forms
09/01/2010EP2222376A2 3-(2,2,2-trimethylhydrazinium) propionate salts for treating ischemic heart disease
09/01/2010EP2222300A1 Method and composition for treating a serotonin receptor-mediated condition
09/01/2010EP2222293A1 Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate
09/01/2010EP2057122B1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the 2 adrenergic receptor
09/01/2010EP2004657B1 Condensed imidazole derivatives as aldosterone synthase inhibitors
09/01/2010EP1998778B1 Use of (s)-roscovitine for the prevention and/or treatment of neurological disorders
09/01/2010EP1854787B1 Novel cyclic compound having quinolylalkylthio group
09/01/2010EP1430027B1 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
09/01/2010EP1408117B1 Glycoprotein and process for producing the same
09/01/2010EP1337558B1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
09/01/2010EP1028942B1 Dipeptide nitriles
1 ... 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 ... 1595